Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Chemotherapy-related Cardiomyopathy in Patients With Breast Cancer Using Cardiac Magnetic Resonance

NCT04510532 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04510532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04510532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Chemotherapy-related Cardiomyopathy in Patients With Breast Cancer Using Cardiac Magnetic Resonance
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 30, 2020
Completion date
September 30, 2023
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapy induced systolic dysfunction